Garliss CC - Search Results

1

A Comparison of Different Immune Activation Strategies to Reverse HIV-1 Latency.

Garliss CC, Kwaa AK, Blankson JN. Garliss CC, et al. Open Forum Infect Dis. 2020 Mar 4;7(4):ofaa082. doi: 10.1093/ofid/ofaa082. eCollection 2020 Apr. Open Forum Infect Dis. 2020. PMID: 32284948 Free PMC article.

2

A CD3/CD28 microbead-based HIV-1 viral outgrowth assay.

Kuzmichev YV, Veenhuis RT, Pohlmeyer CW, Garliss CC, Walker-Sperling VE, Blankson JN. Kuzmichev YV, et al. Among authors: garliss cc. J Virus Erad. 2017 Apr 1;3(2):85-89. J Virus Erad. 2017. PMID: 28435692 Free PMC article.

3

Long-term remission despite clonal expansion of replication-competent HIV-1 isolates.

Veenhuis RT, Kwaa AK, Garliss CC, Latanich R, Salgado M, Pohlmeyer CW, Nobles CL, Gregg J, Scully EP, Bailey JR, Bushman FD, Blankson JN. Veenhuis RT, et al. Among authors: garliss cc. JCI Insight. 2018 Sep 20;3(18):e122795. doi: 10.1172/jci.insight.122795. eCollection 2018 Sep 20. JCI Insight. 2018. PMID: 30232278 Free PMC article.

4

Elite suppressors have low frequencies of intact HIV-1 proviral DNA.

Kwaa AK, Garliss CC, Ritter KD, Laird GM, Blankson JN. Kwaa AK, et al. Among authors: garliss cc. AIDS. 2020 Mar 15;34(4):641-643. doi: 10.1097/QAD.0000000000002474. AIDS. 2020. PMID: 31895150 Free PMC article.

5

A T Cell Receptor Sequencing-Based Assay Identifies Cross-Reactive Recall CD8⁺ T Cell Clonotypes Against Autologous HIV-1 Epitope Variants.

Chan HY, Zhang J, Garliss CC, Kwaa AK, Blankson JN, Smith KN. Chan HY, et al. Among authors: garliss cc. Front Immunol. 2020 Apr 7;11:591. doi: 10.3389/fimmu.2020.00591. eCollection 2020. Front Immunol. 2020. PMID: 32318072 Free PMC article.

6

Healthy donor T cell responses to common cold coronaviruses and SARS-CoV-2.

Woldemeskel BA, Kwaa AK, Garliss CC, Laeyendecker O, Ray SC, Blankson JN. Woldemeskel BA, et al. Among authors: garliss cc. J Clin Invest. 2020 Dec 1;130(12):6631-6638. doi: 10.1172/JCI143120. J Clin Invest. 2020. PMID: 32966269 Free PMC article. Clinical Trial.

7

The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living With Human Immunodeficiency Virus (HIV).

Woldemeskel BA, Karaba AH, Garliss CC, Beck EJ, Wang KH, Laeyendecker O, Cox AL, Blankson JN. Woldemeskel BA, et al. Among authors: garliss cc. Clin Infect Dis. 2022 Apr 9;74(7):1268-1270. doi: 10.1093/cid/ciab648. Clin Infect Dis. 2022. PMID: 34293114 Free PMC article.

8

CD8 Effector T Cells Function Synergistically With Broadly Neutralizing Antibodies to Enhance Suppression of HIV Infection.

Veenhuis RT, Garliss CC, Bailey JR, Blankson JN. Veenhuis RT, et al. Among authors: garliss cc. Front Immunol. 2021 Jul 29;12:708355. doi: 10.3389/fimmu.2021.708355. eCollection 2021. Front Immunol. 2021. PMID: 34394110 Free PMC article.

9

mRNA Vaccine-Elicited Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T Cells Persist at 6 Months and Recognize the Delta Variant.

Woldemeskel BA, Garliss CC, Blankson JN. Woldemeskel BA, et al. Among authors: garliss cc. Clin Infect Dis. 2022 Aug 24;75(1):e898-e901. doi: 10.1093/cid/ciab915. Clin Infect Dis. 2022. PMID: 34694362

10

Discordant Antibody and T-Cell Responses to the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in Coronavirus Disease 2019 Messenger RNA Vaccine Recipients.

Woldemeskel BA, Garliss CC, Aytenfisu TY, Johnston TS, Cox AL, Karaba AH, Blankson JN. Woldemeskel BA, et al. Among authors: garliss cc. Clin Infect Dis. 2022 Oct 29;75(9):1652-1654. doi: 10.1093/cid/ciac305. Clin Infect Dis. 2022. PMID: 35438751 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page